Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00236938Phase 3Completed
Phase 3, randomised, open-label trial of iron sucrose in anemia (2 arms), sponsored by American Regent, Inc. Primary endpoint: Mean Change From Baseline to the Highest Hemoglobin up to Day 71. Started Jul 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00236938.